State Ledger
Company profile

AIM ImmunoTech Inc. CIK 946644

Ticker
AIM (NYSE)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Ocala, FL 32801
Fiscal year end
2025 (FY)
Market Data
Close
$0.18
Change
-$0.00
Change %
-0.17%
Volume
3,323

AIM · trading date Oct 9, 2026 · previous close $0.18 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$88.0K
Net income
-$13.96M
Total assets
$5.78M
Total liabilities
$15.57M
Stockholders' equity
-$9.78M
Cash & equivalents
$2.99M
Operating income
-$11.66M
Operating cash flow
-$10.96M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-27. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-13,254.5%
Net margin
-15,861.4%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
269.2%
Equity / assets
-169.2%
CapEx / revenue
—
Operating cash flow / net income
0.78×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $88.0K -$13.96M $5.78M $15.57M -$9.78M
2024 $170.0K -$17.32M $8.61M $9.93M -$1.32M
2023 $202.0K -$28.96M $19.38M $9.15M $10.23M
2022 $141.0K -$19.45M $40.49M $2.02M $38.47M
2021 $135.0K -$19.13M $57.70M — $56.88M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-27

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Ocala, FL 32801
2117 SW HIGHWAY 484
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:24 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Florida — Public Companies